Laura Carrassa

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 9

Top Venues

Molecular cancer therapeutics

Cancers

Clinical cancer research : an official journal of the American Association for Cancer Research

Cells

Mario Negri Institute for Pharmacological Research

Mario Negri Institute for Pharmacological Research (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Mario Negri Institute for Pharmacological Research

Italy

Staff-Senior Researcher :: Oncology

Mario Negri Institute for Pharmacological Research

Italy

Post Doctoral Fellowship :: Oncology

Mario Negri Institute for Pharmacological Research

Italy

PhD student :: Oncology

University of Cincinnati

United States

PhD student :: Molecular Genetics

Mario Negri Institute for Pharmacological Research

Italy

research fellow funded by AIRC :: oncology

Mario Negri Institute for Pharmacological Research

Italy

Attending Student :: Oncology

Education History

Mario Negri Institute for Pharmacological Research

Italy

PHD :: Oncology

Publications

Giulia Anichini, Chiara Raggi, Mirella Pastore, Laura Carrassa, Luisa Maresca, Enrica Crivaro, Tiziano Lottini, Lea Duwe, Jesper B Andersen, Lorenzo Tofani, Luca Di Tommaso, Jesus Maria Banales, Annarosa Arcangeli, Fabio Marra, Barbara Stecca
Combined Inhibition of Smoothened and the DNA Damage Checkpoint WEE1 Exerts Antitumor Activity in Cholangiocarcinoma. Molecular cancer therapeutics 22 (3) (2023)
Giulia Anichini, Chiara Raggi, Mirella Pastore, Laura Carrassa, Luisa Maresca, Enrica Crivaro, Tiziano Lottini, Lea Duwe, Jesper B Andersen, Lorenzo Tofani, Luca Di Tommaso, Jesus Maria Banales, Annarosa Arcangeli, Fabio Marra, Barbara Stecca
Combined Inhibition of Smoothened and the DNA Damage Checkpoint WEE1 Exerts Antitumor Activity in Cholangiocarcinoma. Molecular cancer therapeutics 22 (3) (2023)
Giulia Anichini, Chiara Raggi, Mirella Pastore, Laura Carrassa, Luisa Maresca, Enrica Crivaro, Tiziano Lottini, Lea Duwe, Jesper B Andersen, Lorenzo Tofani, Luca Di Tommaso, Jesus Maria Banales, Annarosa Arcangeli, Fabio Marra, Barbara Stecca
Combined Inhibition of Smoothened and the DNA Damage Checkpoint WEE1 Exerts Antitumor Activity in Cholangiocarcinoma. Molecular cancer therapeutics 22 (3) (2023)
Giulia Anichini, Chiara Raggi, Mirella Pastore, Laura Carrassa, Luisa Maresca, Enrica Crivaro, Tiziano Lottini, Lea Duwe, Jesper B Andersen, Lorenzo Tofani, Luca Di Tommaso, Jesus Maria Banales, Annarosa Arcangeli, Fabio Marra, Barbara Stecca
Combined Inhibition of Smoothened and the DNA Damage Checkpoint WEE1 Exerts Antitumor Activity in Cholangiocarcinoma. Molecular cancer therapeutics (2023)
Giulia Anichini, Chiara Raggi, Mirella Pastore, Laura Carrassa, Luisa Maresca, Enrica Crivaro, Tiziano Lottini, Lea Duwe, Jesper B Andersen, Lorenzo Tofani, Luca Di Tommaso, Jesus Maria Banales, Annarosa Arcangeli, Fabio Marra, Barbara Stecca
Combined Inhibition of Smoothened and the DNA Damage Checkpoint WEE1 Exerts Antitumor Activity in Cholangiocarcinoma. Molecular cancer therapeutics 22 (3) (2023)
Luisa Maresca, Barbara Stecca, Laura Carrassa
Novel Therapeutic Approaches with DNA Damage Response Inhibitors for Melanoma Treatment. Cells 11 (9) (2022)
Giulia Anichini, Laura Carrassa, Barbara Stecca, Fabio Marra, Chiara Raggi
The Role of the Hedgehog Pathway in Cholangiocarcinoma. Cancers 13 (19) (2021)
Valentina Restelli, Monica Lupi, Rosaria Chilà, Micaela Vagni, Chiara Tarantelli, Filippo Spriano, Eugenio Gaudio, Francesco Bertoni, Giovanna Damia, Laura Carrassa
DNA Damage Response Inhibitor Combinations Exert Synergistic Antitumor Activity in Aggressive B-Cell Lymphomas. Molecular cancer therapeutics 18 (7) (2019)
Roberta Frapolli, Ezia Bello, Marianna Ponzo, Ilaria Craparotta, Laura Mannarino, Sara Ballabio, Sergio Marchini, Laura Carrassa, Paolo Ubezio, Luca Porcu, Silvia Brich, Roberta Sanfilippo, Paolo Giovanni Casali, Alessandro Gronchi, Silvana Pilotti, Maurizio D'Incalci
Combination of PPARγ Agonist Pioglitazone and Trabectedin Induce Adipocyte Differentiation to Overcome Trabectedin Resistance in Myxoid Liposarcomas. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (24) (2019)

Laura Carrassa.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Laura Carrassa